{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T03:27:48Z","timestamp":1772767668299,"version":"3.50.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1038\/ncprheum0432","type":"journal-article","created":{"date-parts":[[2007,3,2]],"date-time":"2007-03-02T20:46:46Z","timestamp":1172868406000},"page":"140-147","source":"Crossref","is-referenced-by-count":55,"title":["The antiphospholipid syndrome as a disorder initiated by inflammation: implications for the therapy of pregnant patients"],"prefix":"10.1038","volume":"3","author":[{"given":"Jane E","family":"Salmon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermina","family":"Girardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D","family":"Lockshin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFncprheum0432_CR1","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","volume":"42","author":"WA Wilson","year":"1999","unstructured":"Wilson WA  et al. (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42: 1309\u20131311","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0432_CR2","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S  et al. (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4: 295\u2013306","journal-title":"J Thromb Haemost"},{"key":"BFncprheum0432_CR3","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1073\/pnas.87.11.4120","volume":"87","author":"HP McNeil","year":"1990","unstructured":"McNeil HP  et al. (1990) Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 87: 4120\u20134124","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncprheum0432_CR4","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1016\/0140-6736(90)91374-J","volume":"335","author":"M Galli","year":"1990","unstructured":"Galli M  et al. (1990) Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 335: 1544\u20131547","journal-title":"Lancet"},{"key":"BFncprheum0432_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0140-6736(90)91697-9","volume":"336","author":"E Matsuura","year":"1990","unstructured":"Matsuura E  et al. (1990) Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 336: 177\u2013178","journal-title":"Lancet"},{"key":"BFncprheum0432_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S0015-0282(16)58382-4","volume":"66","author":"MD Stephenson","year":"1996","unstructured":"Stephenson MD (1996) Frequency of factors associated with habitual abortion in 197 couples. Fertil Steril 66: 24\u201329","journal-title":"Fertil Steril"},{"key":"BFncprheum0432_CR7","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/art.1780400322","volume":"40","author":"N Del Papa","year":"1997","unstructured":"Del Papa N  et al. (1997) Endothelial cells as a target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-beta 2-glycoprotein I antibodies react in vitro with endothelial cells through adherent beta 2-glycoprotein I and induce endothelial activation. Arthritis Rheum 40: 551\u2013561","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0432_CR8","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1172\/JCI118276","volume":"96","author":"R Simantov","year":"1995","unstructured":"Simantov R  et al. (1995) Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J Clin Invest 96: 2211\u20132219","journal-title":"J Clin Invest"},{"key":"BFncprheum0432_CR9","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1182\/blood-2004-01-0145","volume":"104","author":"H Zhou","year":"2004","unstructured":"Zhou H  et al. (2004) Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep. Blood 104: 2353\u20132358","journal-title":"Blood"},{"key":"BFncprheum0432_CR10","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1182\/blood-2002-08-2349","volume":"101","author":"E Raschi","year":"2003","unstructured":"Raschi E  et al. (2003) Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. Blood 101: 3495\u20133500","journal-title":"Blood"},{"key":"BFncprheum0432_CR11","doi-asserted-by":"publisher","first-page":"15541","DOI":"10.1074\/jbc.275.20.15541","volume":"275","author":"K Ma","year":"2000","unstructured":"Ma K  et al. (2000) High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin II. J Biol Chem 275: 15541\u201315548","journal-title":"J Biol Chem"},{"key":"BFncprheum0432_CR12","doi-asserted-by":"publisher","first-page":"33831","DOI":"10.1074\/jbc.M212655200","volume":"278","author":"BC Lutters","year":"2003","unstructured":"Lutters BC  et al. (2003) Dimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2'. J Biol Chem 278: 33831\u201333838","journal-title":"J Biol Chem"},{"key":"BFncprheum0432_CR13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.thromres.2004.07.021","volume":"114","author":"JH Rand","year":"2004","unstructured":"Rand JH and Wu XX (2004) Antibody-mediated interference with annexins in the antiphospholipid syndrome. Thromb Res 114: 383\u2013389","journal-title":"Thromb Res"},{"key":"BFncprheum0432_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1080\/08916930500124312","volume":"38","author":"T Atsumi","year":"2005","unstructured":"Atsumi T  et al. (2005) Research around beta 2-glycoprotein I: a major target for antiphospholipid antibodies. Autoimmunity 38: 377\u2013381","journal-title":"Autoimmunity"},{"key":"BFncprheum0432_CR15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/1529-0131(200001)43:1<140::AID-ANR18>3.0.CO;2-P","volume":"43","author":"N Di Simone","year":"2000","unstructured":"Di Simone N  et al. (2000) Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I. Arthritis Rheum 43: 140\u2013150","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0432_CR16","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1002\/art.20105","volume":"50","author":"RH Derksen","year":"2004","unstructured":"Derksen RH  et al. (2004) Management of the obstetric antiphospholipid syndrome. Arthritis Rheum 50: 1028\u20131039","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0432_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1084\/jem.200116116","volume":"195","author":"VM Holers","year":"2002","unstructured":"Holers VM  et al. (2002) Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med 195: 211\u2013220","journal-title":"J Exp Med"},{"key":"BFncprheum0432_CR18","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1172\/JCI200318817","volume":"112","author":"G Girardi","year":"2003","unstructured":"Girardi G  et al. (2003) Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest 112: 1644\u20131654","journal-title":"J Clin Invest"},{"key":"BFncprheum0432_CR19","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1002\/art.21157","volume":"52","author":"SS Pierangeli","year":"2005","unstructured":"Pierangeli SS  et al. (2005) Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia. Arthritis Rheum 52: 2120\u20132124","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0432_CR20","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1126\/science.287.5452.498","volume":"287","author":"C Xu","year":"2000","unstructured":"Xu C  et al. (2000) A critical role for murine complement regulator crry in fetomaternal tolerance. Science 287: 498\u2013501","journal-title":"Science"},{"key":"BFncprheum0432_CR21","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S1074-7613(03)00321-2","volume":"19","author":"D Mao","year":"2003","unstructured":"Mao D  et al. (2003) Negligible role of antibodies and C5 in pregnancy loss associated exclusively with C3-dependent mechanisms through complement alternative pathway. Immunity 19: 813\u2013822","journal-title":"Immunity"},{"key":"BFncprheum0432_CR22","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.placenta.2005.04.006","volume":"27","author":"S Stone","year":"2006","unstructured":"Stone S  et al. (2006) The placental bed in pregnancies complicated by primary antiphospholipid syndrome. Placenta 27: 457\u2013467","journal-title":"Placenta"},{"key":"BFncprheum0432_CR23","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1093\/humrep\/deh844","volume":"20","author":"S Quenby","year":"2005","unstructured":"Quenby S  et al. (2005) Recurrent miscarriage and long-term thrombosis risk: a case-control study. Hum Reprod 20: 1729\u20131732","journal-title":"Hum Reprod"},{"key":"BFncprheum0432_CR24","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1136\/ard.2003.019000","volume":"64","author":"D Le Thi Thuong","year":"2005","unstructured":"Le Thi Thuong D  et al. (2005) The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women. Ann Rheum Dis 64: 273\u2013278","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0432_CR25","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1191\/096120399680411272","volume":"8","author":"JP Buyon","year":"1999","unstructured":"Buyon JP  et al. (1999) Assessing disease activity in SLE patients during pregnancy. Lupus 8: 677\u2013684","journal-title":"Lupus"},{"key":"BFncprheum0432_CR26","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S0002-9378(98)70277-7","volume":"179","author":"MS Magid","year":"1998","unstructured":"Magid MS  et al. (1998) Placental pathology in systemic lupus erythematosus: a prospective study. Am J Obstet Gynecol 179: 226\u2013234","journal-title":"Am J Obstet Gynecol"},{"key":"BFncprheum0432_CR27","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1055\/s-2007-994176","volume":"14","author":"CM Salafia","year":"1997","unstructured":"Salafia CM and Cowchock FS (1997) Placental pathology and antiphospholipid antibodies: a descriptive study. Am J Perinatol 14: 435\u2013441","journal-title":"Am J Perinatol"},{"key":"BFncprheum0432_CR28","first-page":"1684","volume":"21","author":"L La Rosa","year":"1994","unstructured":"La Rosa L  et al. (1994) Beta 2 glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid syndrome. J Rheumatol 21: 1684\u20131693","journal-title":"J Rheumatol"},{"key":"BFncprheum0432_CR29","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1001\/archpedi.157.4.397","volume":"157","author":"G Ross","year":"2003","unstructured":"Ross G  et al. (2003) Effects of mothers' autoimmune disease during pregnancy on learning disabilities and hand preference in their children. Arch Pediatr Adolesc Med 157: 397\u2013402","journal-title":"Arch Pediatr Adolesc Med"},{"key":"BFncprheum0432_CR30","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1191\/0961203304lu2018oa","volume":"13","author":"F Neri","year":"2004","unstructured":"Neri F  et al. (2004) Neuropsychological development of children born to patients with systemic lupus erythematosus. Lupus 13: 805\u2013811","journal-title":"Lupus"},{"key":"BFncprheum0432_CR31","doi-asserted-by":"crossref","unstructured":"Empson M  et al. (2005) Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. The Cochrane Database of Systematic Reviews, Issue 2, Art. No CD002859","DOI":"10.1002\/14651858.CD002859.pub2"},{"key":"BFncprheum0432_CR32","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.thromres.2004.08.006","volume":"114","author":"M Lassere","year":"2004","unstructured":"Lassere M and Empson M (2004) Treatment of antiphospholipid syndrome in pregnancy--a systematic review of randomized therapeutic trials. Thromb Res 114: 419\u2013426","journal-title":"Thromb Res"},{"key":"BFncprheum0432_CR33","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/0002-9378(92)91596-3","volume":"166","author":"FS Cowchock","year":"1992","unstructured":"Cowchock FS  et al. (1992) Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 166: 1318\u20131323","journal-title":"Am J Obstet Gynecol"},{"key":"BFncprheum0432_CR34","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/0002-9378(93)90410-K","volume":"169","author":"RK Silver","year":"1993","unstructured":"Silver RK  et al. (1993) Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am J Obstet Gynecol 169: 1411\u20131417","journal-title":"Am J Obstet Gynecol"},{"key":"BFncprheum0432_CR35","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1016\/S0002-9378(96)70610-5","volume":"174","author":"WH Kutteh","year":"1996","unstructured":"Kutteh WH (1996) Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 174: 1584\u20131589","journal-title":"Am J Obstet Gynecol"},{"key":"BFncprheum0432_CR36","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1136\/bmj.314.7076.253","volume":"314","author":"R Rai","year":"1997","unstructured":"Rai R  et al. (1997) Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 314: 253\u2013257","journal-title":"BMJ"},{"key":"BFncprheum0432_CR37","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/00006250-200209000-00004","volume":"100","author":"RG Farquharson","year":"2002","unstructured":"Farquharson RG  et al. (2002) Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol 100: 408\u2013413","journal-title":"Obstet Gynecol"},{"key":"BFncprheum0432_CR38","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jsgi.2004.02.007","volume":"11","author":"MH Ensom","year":"2004","unstructured":"Ensom MH and Stephenson MD (2004) Pharmacokinetics of low molecular weight heparin and unfractionated heparin in pregnancy. J Soc Gynecol Investig 11: 377\u2013383","journal-title":"J Soc Gynecol Investig"},{"key":"BFncprheum0432_CR39","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.fertnstert.2004.11.002","volume":"83","author":"LS Noble","year":"2005","unstructured":"Noble LS  et al. (2005) Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin. Fertil Steril 83: 684\u2013690","journal-title":"Fertil Steril"},{"key":"BFncprheum0432_CR40","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S1701-2163(16)30644-2","volume":"26","author":"MD Stephenson","year":"2004","unstructured":"Stephenson MD  et al. (2004) Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin. J Obstet Gynaecol Can 26: 729\u2013734","journal-title":"J Obstet Gynaecol Can"},{"key":"BFncprheum0432_CR41","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1191\/0961203303lu393oa","volume":"12","author":"A Tincani","year":"2003","unstructured":"Tincani A  et al. (2003) Treatment of pregnant patients with antiphospholipid syndrome. Lupus 12: 524\u2013529","journal-title":"Lupus"},{"key":"BFncprheum0432_CR42","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0146-0005(03)00022-3","volume":"27","author":"BM Sibai","year":"2003","unstructured":"Sibai BM  et al. (2003) What we have learned about preeclampsia. Semin Perinatol 27: 239\u2013246","journal-title":"Semin Perinatol"},{"key":"BFncprheum0432_CR43","unstructured":"Duley L  et al. (2004) Antiplatelet agents for preventing pre-eclampsia and its complications. The Cochrane Database of Systematic Reviews, Issue 1, Art. No CD004659"},{"key":"BFncprheum0432_CR44","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ajog.2004.09.029","volume":"192","author":"P Bose","year":"2005","unstructured":"Bose P  et al. (2005) Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure. Am J Obstet Gynecol 192: 23\u201330","journal-title":"Am J Obstet Gynecol"},{"key":"BFncprheum0432_CR45","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/0002-9378(89)90468-7","volume":"160","author":"MD Lockshin","year":"1989","unstructured":"Lockshin MD  et al. (1989) Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obstet Gynecol 160: 439\u2013443","journal-title":"Am J Obstet Gynecol"},{"key":"BFncprheum0432_CR46","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/00124743-200110000-00007","volume":"7","author":"H Carp","year":"2001","unstructured":"Carp H  et al. (2001) Intravenous immunoglobulin in pregnancies complicated by the antiphospholipid antibody. J Clin Rheumatol 7: 291\u2013294","journal-title":"J Clin Rheumatol"},{"key":"BFncprheum0432_CR47","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1191\/0961203304lu2011oa","volume":"13","author":"G Triolo","year":"2004","unstructured":"Triolo G  et al. (2004) IVIG in APS pregnancy. Lupus 13: 731\u2013735","journal-title":"Lupus"},{"key":"BFncprheum0432_CR48","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S0002-9378(00)70500-X","volume":"182","author":"DW Branch","year":"2000","unstructured":"Branch DW  et al. (2000) A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group. Am J Obstet Gynecol 182: 122\u2013127","journal-title":"Am J Obstet Gynecol"},{"key":"BFncprheum0432_CR49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0268-960X(02)00056-5","volume":"17","author":"KR McCrae","year":"2003","unstructured":"McCrae KR (2003) Thrombocytopenia in pregnancy: differential diagnosis, pathogenesis, and management. Blood Rev 17: 7\u201314","journal-title":"Blood Rev"},{"key":"BFncprheum0432_CR50","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1172\/JCI1509","volume":"101","author":"A Koenig","year":"1998","unstructured":"Koenig A  et al. (1998) Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents. J Clin Invest 101: 877\u2013889","journal-title":"J Clin Invest"},{"key":"BFncprheum0432_CR51","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1172\/JCI0214996","volume":"110","author":"L Wang","year":"2002","unstructured":"Wang L  et al. (2002) Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins. J Clin Invest 110: 127\u2013136","journal-title":"J Clin Invest"},{"key":"BFncprheum0432_CR52","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/PL00000237","volume":"50","author":"MX Wan","year":"2001","unstructured":"Wan MX  et al. (2001) Low molecular weight heparin inhibits tumor necrosis factor alpha-induced leukocyte rolling. Inflamm Res 50: 581\u2013584","journal-title":"Inflamm Res"},{"key":"BFncprheum0432_CR53","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1053\/plac.2002.0923","volume":"24","author":"GE Lash","year":"2003","unstructured":"Lash GE  et al. (2003) Vascular endothelial growth factor is a chemoattractant for trophoblast cells. Placenta 24: 549\u2013556","journal-title":"Placenta"},{"key":"BFncprheum0432_CR54","doi-asserted-by":"crossref","unstructured":"Di Simone N  et al. (2006) Low-molecular Weight Heparin Induces In Vitro Trophoblast Invasiveness: Role of Matrix Metalloproteinases and Tissue Inhibitors. Placenta [doi:10.1016\/j.placenta.2006.04.001]","DOI":"10.1016\/j.placenta.2006.04.001"},{"key":"BFncprheum0432_CR55","doi-asserted-by":"publisher","first-page":"10326","DOI":"10.1073\/pnas.0402597101","volume":"101","author":"T Hamatani","year":"2004","unstructured":"Hamatani T  et al. (2004) Global gene expression analysis identifies molecular pathways distinguishing blastocyst dormancy and activation. Proc Natl Acad Sci USA 101: 10326\u201310331","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncprheum0432_CR56","first-page":"455","volume":"101","author":"RD Franklin","year":"2003","unstructured":"Franklin RD and Kutteh WH (2003) Effects of unfractionated and low molecular weight heparin on antiphospholipid antibody binding in vitro. Obstet Gynecol 101: 455\u2013462","journal-title":"Obstet Gynecol"},{"key":"BFncprheum0432_CR57","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/0049-3848(92)90063-G","volume":"68","author":"DR Wagenknecht","year":"1992","unstructured":"Wagenknecht DR and McIntyre JA (1992) Interaction of heparin with beta 2-glycoprotein I and antiphospholipid antibodies in vitro. Thromb Res 68: 495\u2013500","journal-title":"Thromb Res"},{"key":"BFncprheum0432_CR58","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1074\/jbc.M110176200","volume":"277","author":"J Guerin","year":"2002","unstructured":"Guerin J  et al. (2002) Heparin inhibits the binding of beta 2-glycoprotein I to phospholipids and promotes the plasmin-mediated inactivation of this blood protein. Elucidation of the consequences of the two biological events in patients with the anti-phospholipid syndrome. J Biol Chem 277: 2644\u20132649","journal-title":"J Biol Chem"},{"key":"BFncprheum0432_CR59","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/infdis\/44.3.250","volume":"44","author":"E Ecker","year":"1929","unstructured":"Ecker E and Gross P (1929) Anticomplementary Power of Heparin. J Infect Dis 44: 250","journal-title":"J Infect Dis"},{"key":"BFncprheum0432_CR60","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/0019-2791(76)90202-0","volume":"13","author":"M Loos","year":"1976","unstructured":"Loos M  et al. (1976) Mode of interaction of different polyanions with the first (C1, C1), the second (C2) and the fourth (C4) component of complement-III. Inhibition of C4 and C2 binding site(s) on C1s by polyanions. Immunochemistry 13: 789\u2013791","journal-title":"Immunochemistry"},{"key":"BFncprheum0432_CR61","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1084\/jem.147.2.409","volume":"147","author":"JM Weiler","year":"1978","unstructured":"Weiler JM  et al. (1978) Modulation of the formation of the amplification convertase of complement, C3b, Bb, by native and commercial heparin. J Exp Med 147: 409\u2013421","journal-title":"J Exp Med"},{"key":"BFncprheum0432_CR62","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1172\/JCI110017","volume":"67","author":"MD Kazatchkine","year":"1981","unstructured":"Kazatchkine MD  et al. (1981) Structural determinants of the capacity of heparin to inhibit the formation of the human amplification C3 convertase. J Clin Invest 67: 223\u2013228","journal-title":"J Clin Invest"},{"key":"BFncprheum0432_CR63","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1046\/j.1365-2141.2000.02125.x","volume":"109","author":"H Ninomiya","year":"2000","unstructured":"Ninomiya H  et al. (2000) Inhibition of complement-mediated haemolysis in paroxysmal nocturnal haemoglobinuria by heparin or low-molecular weight heparin. Br J Haematol 109: 875\u2013881","journal-title":"Br J Haematol"},{"key":"BFncprheum0432_CR64","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1038\/nm1121","volume":"10","author":"G Girardi","year":"2004","unstructured":"Girardi G  et al. (2004) Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med 10: 1222\u20131226","journal-title":"Nat Med"},{"key":"BFncprheum0432_CR65","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/art.1780350109","volume":"35","author":"JP Buyon","year":"1992","unstructured":"Buyon JP  et al. (1992) Activation of the alternative complement pathway accompanies disease flares in systemic lupus erythematosus during pregnancy. Arthritis Rheum 35: 55\u201361","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0432_CR66","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1600-0897.1992.tb00787.x","volume":"28","author":"SB Abramson","year":"1992","unstructured":"Abramson SB and Buyon JP (1992) Activation of the complement pathway: comparison of normal pregnancy, preeclampsia, and systemic lupus erythematosus during pregnancy. Am J Reprod Immunol 28: 183\u2013187","journal-title":"Am J Reprod Immunol"},{"key":"BFncprheum0432_CR67","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/art.1780280110","volume":"28","author":"MD Lockshin","year":"1985","unstructured":"Lockshin MD  et al. (1985) Lupus pregnancy. II. Unusual pattern of hypocomplementemia and thrombocytopenia in the pregnant patient. Arthritis Rheum 28: 58\u201366","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0432_CR68","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/0002-9343(86)90251-2","volume":"81","author":"JP Buyon","year":"1986","unstructured":"Buyon JP  et al. (1986) Serum complement values (C3 and C4) to differentiate between systemic lupus activity and pre-eclampsia. Am J Med 81: 194\u2013200","journal-title":"Am J Med"}],"container-title":["Nature Clinical Practice Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0432.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0432","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0432.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T21:03:26Z","timestamp":1684443806000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncprheum0432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["BFncprheum0432"],"URL":"https:\/\/doi.org\/10.1038\/ncprheum0432","relation":{},"ISSN":["1745-8382","1745-8390"],"issn-type":[{"value":"1745-8382","type":"print"},{"value":"1745-8390","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}